Market Overview

Merck's Q3 Earnings Preview


On Thursday, Oct. 25, Merck & Co (NYSE: MRK) will release its latest earnings report. Benzinga's outlook for Merck is included in the following report.

Earnings and Revenue

Sell-side analysts expect Merck's EPS to be near $1.14 on sales of $10.88 billion.

In the same quarter last year, Merck posted a profit of $1.11 on sales of $10.32 billion. The analyst consensus estimate would represent a 2.7 percent increase in the company's EPS figure. Revenue would be have grown 5.38 percent from the same quarter last year. Here's how the company's reported EPS has compared to analyst estimates in the past:


Quarter Q2 2018 Q1 2018 Q4 2017 Q3 2017
EPS Estimate 1.03 0.99 0.93 1.03
EPS Actual 1.06 1.05 0.98 1.11

Stock Performance

Over the last 52-week period, shares are up 12.87 percent. Given that these returns are generally positive, long-term shareholders are probably satisfied going into this earnings release. Analysts have adjusted their estimates higher for EPS and revenues over the past 90 days. The most common rating by analysts on Merck stock is a Neutral. The strength of this rating has maintained conviction over the past three months.

Conference Call

Merck's Q3 is scheduled to hold a conference call at 8:00 a.m. ET and it can be accessed here:

Posted-In: Earnings News


Related Articles (MRK)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

KKR & Co's Q3 Earnings Preview

Tezos Gains On Speculation Of Listing On Coinbase